This Article Full Text Full Text (PDF) All Versions of this Article: 2006-0257OCv1 36/2/236    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Swift, S. M. Articles by Liggett, S. B. Search for Related Content PubMed PubMed Citation Articles by Swift, S. M. Articles by Liggett, S. B.

Pleiotropic -Agonist–Promoted Receptor Conformations and Signals Independent of Intrinsic Activity

Department of Medicine, Cardiopulmonary Genomics Program, University of Maryland School of Medicine, Baltimore, Maryland

Correspondence and requests for reprints should be addressed to Stephen B. Liggett, Department of Medicine, Cardiopulmonary Genomics Program, University of Maryland School of Medicine, 20 Penn Street, HSF-II, Room S-114, Baltimore, MD 21201-1075. E-mail: sligg001{at}umaryland.edu

-Agonists used for treatment of obstructive lung disease have a variety of different structures but are typically classified by their intrinsic activities for stimulation of cAMP, and predictions are made concerning other downstream signals based on such a classification. We generated modified ₂-adrenergic receptors with insertions of energy donor and acceptor moieties to monitor agonist-promoted conformational changes of the receptor using intramolecular bioluminescence resonance energy transfer in live cells. These studies suggested unique conformations stabilized by various agonists that were not based on their classic intrinsic activities. To address the cellular consequences of these differences, G_s-coupling, G_i-coupling (p44/p42 activation), G protein–coupled receptor kinase–mediated receptor phosphorylation, internalization, and down-regulation were assessed in response to isoproterenol, albuterol, terbutaline, metaproterenol, salmeterol, formoterol, and fenoterol. In virtually every case, agonists did not maintain the classic rank order, indicating that distinct signaling is evoked by -agonists of different structures, which is unrelated to intrinsic activity. The extensive pleiotropy of agonist responses shown here suggests that classification of agonists by cAMP-based intrinsic activity is inadequate as it pertains to other intracellular events and that it may be possible to engineer a -agonist that stabilizes conformations that evoke an ideal portfolio of signals for therapeutic purposes.

Key Words: -agonist • -adrenergic receptor • adenylyl cyclase • G-protein • asthma

CLINICAL RELEVANCE We show that -agonists commonly used to treat obstructive lung disease confer different conformations of the 2-adrenergic receptor, which results in different downstream signaling.

 

This article has been cited by other articles:

				G. W. Dorn II and S. B. Liggett Mechanisms of Pharmacogenomic Effects of Genetic Variation within the Cardiac Adrenergic Network in Heart Failure Mol. Pharmacol., September 1, 2009; 76(3): 466 - 480. [Abstract] [Full Text] [PDF]

				S. Matalon and K. B. Adler Highlights of the April Issue Am. J. Respir. Cell Mol. Biol., April 1, 2009; 40(4): 383 - 384. [Full Text] [PDF]